Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital.
作者信息
de Almeida Lara M, de Araújo Maria Rita E, Iwasaki Marta F, Sacramento Andrey G, Rocha Darlan, da Silva Leila P, Pavez Mónica, de Brito Artemir C, Ito Laís Carolina S, Gales Ana C, Lincopan Nilton, Sampaio Jorge L M, Mamizuka Elsa M
机构信息
Department of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil.
出版信息
Antimicrob Agents Chemother. 2014 May;58(5):2993-4. doi: 10.1128/AAC.02399-14. Epub 2014 Mar 10.
Abstract
摘要
相似文献
1
Linezolid resistance in vancomycin-resistant Enterococcus faecalis and Enterococcus faecium isolates in a Brazilian hospital.巴西一家医院中耐万古霉素粪肠球菌和屎肠球菌分离株对利奈唑胺的耐药性
Antimicrob Agents Chemother. 2014 May;58(5):2993-4. doi: 10.1128/AAC.02399-14. Epub 2014 Mar 10.
2
In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals.利奈唑胺对巴西医院分离出的耐万古霉素肠球菌的体外抗菌活性。
Braz J Infect Dis. 2001 Oct;5(5):243-51. doi: 10.1590/s1413-86702001000500002. Epub 2003 Feb 21.
3
Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.粪肠球菌和屎肠球菌中的基因剂量与利奈唑胺耐药性
Antimicrob Agents Chemother. 2002 Oct;46(10):3334-6. doi: 10.1128/AAC.46.10.3334-3336.2002.
4
Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium.恶唑烷酮类化合物依哌唑胺（PNU - 100592）和利奈唑胺（PNU - 100766）与万古霉素相比，对金黄色葡萄球菌、凝固酶阴性葡萄球菌、粪肠球菌和屎肠球菌的体外比较活性及抗生素后效应。
Antimicrob Agents Chemother. 1998 Mar;42(3):721-4. doi: 10.1128/AAC.42.3.721.
5
In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.利奈唑胺对万古霉素敏感及耐药粪肠球菌和屎肠球菌耐药性选择的体外分析
Int J Antimicrob Agents. 2009 Jul;34(1):21-4. doi: 10.1016/j.ijantimicag.2008.12.011. Epub 2009 Feb 24.
6
Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.重症监护病房中耐(linezolid)利奈唑烷(Enterococcus faecalis)肠球菌和屎肠球菌的多个克隆株的传播。
J Antimicrob Chemother. 2012 Aug;67(8):1819-23. doi: 10.1093/jac/dks146. Epub 2012 Apr 24.
7
Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.从奥地利同一重症监护病房的两名患者中分离出的新型耐利奈唑胺粪肠球菌和屎肠球菌。
Eur J Clin Microbiol Infect Dis. 2002 Oct;21(10):751-4. doi: 10.1007/s10096-002-0807-0. Epub 2002 Sep 13.
8
The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.评估万古霉素耐药性负担时调整肠球菌种属的重要性：一项包括 1000 多例肠球菌血流感染病例的队列研究。
Antimicrob Resist Infect Control. 2018 Nov 14;7:133. doi: 10.1186/s13756-018-0419-9. eCollection 2018.
9
Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.恶唑烷酮类药物利奈唑胺和依哌唑胺在粪肠球菌或耐万古霉素屎肠球菌所致实验性腹腔内脓肿中的活性。
Antimicrob Agents Chemother. 1999 Dec;43(12):2873-6. doi: 10.1128/AAC.43.12.2873.
10
Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.中国多中心研究中耐利奈唑胺的肠球菌和科氏葡萄球菌临床分离株：分子流行病学和耐药机制。
Int J Antimicrob Agents. 2013 Oct;42(4):317-21. doi: 10.1016/j.ijantimicag.2013.06.008. Epub 2013 Jul 20.
引用本文的文献
1
Antibiotic Practice Change to Curtail Linezolid Use in Pediatric Hospitalized Patients in Hawai'i with Uncomplicated Skin and Soft Tissue Infections.抗生素实践的改变以减少夏威夷住院患儿中单纯皮肤和软组织感染使用利奈唑胺的情况。
Hawaii J Health Soc Welf. 2020 May 1;79(5 Suppl 1):87-90.
2
Probiotic Cocktail Identified by Microbial Network Analysis Inhibits Growth, Virulence Gene Expression, and Host Cell Colonization of Vancomycin-Resistant Enterococci.通过微生物网络分析鉴定的益生菌鸡尾酒可抑制耐万古霉素肠球菌的生长、毒力基因表达及宿主细胞定植。
Microorganisms. 2020 May 29;8(6):816. doi: 10.3390/microorganisms8060816.
3
Vancomycin-resistant enterococcal infection in a Thai university hospital: clinical characteristics, treatment outcomes, and synergistic effect.泰国一家大学医院的耐万古霉素肠球菌感染：临床特征、治疗结果及协同效应
Infect Drug Resist. 2019 Jul 11;12:2049-2057. doi: 10.2147/IDR.S208298. eCollection 2019.
4
Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).将埃斯硒林重新用于去定植万古霉素耐药肠球菌（VRE）。
PLoS One. 2018 Jun 28;13(6):e0199710. doi: 10.1371/journal.pone.0199710. eCollection 2018.
5
Prevalence and Antimicrobial Resistance of Enterococci Isolated from Retail Meats in the United States, 2002 to 2014.2002年至2014年美国零售肉类中分离出的肠球菌的流行情况及耐药性
Appl Environ Microbiol. 2017 Dec 15;84(1). doi: 10.1128/AEM.01902-17. Print 2018 Jan 1.
本文引用的文献
1
Linezolid resistance in Brazilian Staphylococcus hominis strains is associated with L3 and 23S rRNA ribosomal mutations.巴西人葡萄球菌菌株中的利奈唑胺耐药性与L3和23S rRNA核糖体突变有关。
Antimicrob Agents Chemother. 2013 Aug;57(8):4082-3. doi: 10.1128/AAC.00437-13. Epub 2013 May 20.
2
First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea.韩国首次报告一株耐利奈唑胺和万古霉素的粪肠球菌菌株。
Scand J Infect Dis. 2006;38(5):383-6. doi: 10.1080/00365540500372945.
3
First report of a linezolid-resistant vancomycin-resistant Enterococcus faecium strain in Greece.
J Antimicrob Chemother. 2004 Apr;53(4):685-6. doi: 10.1093/jac/dkh131. Epub 2004 Feb 25.
4
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid.耐万古霉素的屎肠球菌对利奈唑胺耐药导致的感染。
Lancet. 2001 Apr 14;357(9263):1179. doi: 10.1016/S0140-6736(00)04376-2.
Zotero 插件